DocDollars

Acrotech Biopharma Inc.

NJ · United States · Reporting entity ID 100000981882

Total reported 2019–2025
$8.05M
#559 of 2,960 reporting companies — 0% of all reported industry payments
$1.34M in general payments across 7,747 records, plus $6.71M in research funding across 888 records.

How it breaks down

General payments $1,338,526
Research funding $6,714,932

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Acrotech Biopharma Inc. reported $8.05M to US doctors and teaching hospitals from 2019 to 2025, ranking #559 of 2,960 reporting companies. 83% of that was research funding and 17% general payments such as consulting, speaking, food and travel. 7,747 general payment records and 888 research records were filed.

Common questions about Acrotech Biopharma Inc.

How much has Acrotech Biopharma Inc. paid US doctors?

Acrotech Biopharma Inc. reported $8,053,457 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,338,526 in general payments, $6,714,932 in research funding.

How does Acrotech Biopharma Inc. rank among drug and device companies?

It ranks #559 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Acrotech Biopharma Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.